Gilead Sciences, Inc. - GILD - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Gilead Sciences, Inc. - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
GILD	Nasdaq	8731	http://www.gilead.com/	55.85 -0.45
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Gilead Sciences, Inc. Early Glance: Biotechnology companies - May 20th, 2013 8:31 am Early Glance: Biotechnology companies - May 20th, 2013 8:31 am Tackling Cancer: Leukemia's Biggest Current and Upcoming Players - May 19th, 2013 4:30 pm 3 Horrendous Health-Care Stocks This Week - May 18th, 2013 6:45 am Final Glance: Biotechnology companies - May 17th, 2013 4:03 pm Final Glance: Biotechnology companies - May 17th, 2013 4:03 pm Staples Launches Sports & Art Photo Gallery and 2 More Heavily Traded Stocks to Follow - May 17th, 2013 2:49 pm Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20 - May 17th, 2013 2:05 pm Midday Glance: Biotechnology companies - May 17th, 2013 11:32 am Midday Glance: Biotechnology companies - May 17th, 2013 11:32 am Jim Cramer: Buy Gilead Sciences, Kinder Morgan, and These 3 Solid Stocks Now - May 17th, 2013 10:22 am Bypassing Biotechs and Focusing on the Overlooked Medical Device Space: An Expert Portfolio Manager Discusses His Contrarian Approach to Investing - May 17th, 2013 9:07 am Analyst Moves: NOC, GM, GILD - May 17th, 2013 8:45 am Cramer's Lightning Round - I've Had It With Magnum Hunter (5/16/13) - May 17th, 2013 4:20 am 'Mad Money' Lightning Round: Magnum Hunter Blew It - May 17th, 2013 4:00 am [$$] AbbVie Is Good Medicine - May 16th, 2013 5:15 pm Lightning Round: Starbucks, Gilead & More - May 16th, 2013 4:42 pm Eyeing Business Models and Practices that are Sustainable and Value-Creating in the Biotech and Pharmaceutical Sectors - May 16th, 2013 1:35 pm Gilead Drug For Leukemia Shows Success In Early Trial - May 16th, 2013 1:29 pm [video] Biotech's Next Big Thing -- ASCO II - May 16th, 2013 12:09 pm View All Current Headlines >>